Product Information
IMATINIB MESYLATE 100 MG TAB is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.6114 per EA under NDC 43598034431. Its NADAC has been published 258 times since Oct 14, 2020.
FDA first approved this application on Aug 13, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598034431
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA206547FDA Approved
8/13/2018
TE Code
AB
On Market Since
8/13/2018
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 100 MG TAB has been published 258 times since Oct 14, 2020, and over the history we have for it it has declined 80.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6114 per EA |
|---|---|
| All-time high | $3.1369 (Jul 14, 2021) |
| All-time low | $0.3890 (May 22, 2024) |
| 52-week high | $0.9761 |
| 52-week low | $0.6114 |
| Median price | $0.7406 |
| Average price | $1.0815 |
| Largest weekly change | -74.1% (Jun 22, 2022) |
| Weeks tracked | 258 |
| Tracking since | Oct 14, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 100 MG TAB, manufactured by Dr. Reddy's Laboratories Inc., is $0.6114 per EA (NDC 43598034431), effective Aug 19, 2026.
How has the price of IMATINIB MESYLATE 100 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 100 MG TAB has declined 80.5%. It has been tracked across 258 weekly CMS publications since Oct 14, 2020.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 100 MG TAB?
Since Oct 14, 2020, the NADAC for IMATINIB MESYLATE 100 MG TAB has ranged from a low of $0.3890 (May 22, 2024) to a high of $3.1369 (Jul 14, 2021), with a median of $0.7406 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 100 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as IMATINIB MESYLATE 100 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures IMATINIB MESYLATE 100 MG TAB?
IMATINIB MESYLATE 100 MG TAB (NDC 43598034431) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.